Overexpression of Rad51 predicts poor prognosis and silencing of Rad51 increases chemo-sensitivity to doxorubicin in neuroblastoma.

Xu, Yonghu; Chen, Kai; Cai, Yuanxia; Cheng, Cheng; Zhang, Zihan; Xu, Guofeng

Xu, Yonghu; Chen, Kai; Cai, Yuanxia; Cheng, Cheng; Zhang, Zihan; Xu, Guofeng.

Afiliación

Xu Y; Department of Pediatric Urology, Xinhua Hospital, National Key Clinical Specialty, Shanghai Top-Priority Clinical Center, School of Medicine, Shanghai Jiaotong University Shanghai 200092, China.
Chen K; Department of Pediatric Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200092, China.
Cai Y; Division of Pediatric Oncology, Shanghai Institute of Pediatric Research Shanghai 200092, China.
Cheng C; Department of Pediatric Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200092, China.
Zhang Z; Division of Pediatric Oncology, Shanghai Institute of Pediatric Research Shanghai 200092, China.
Xu G; Department of Pediatric Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200092, China.

Am J Transl Res ; 11(9): 5788-5799, 2019.

Article en En | MEDLINE | ID: mdl-31632548

Palabras clave

Rad51; chemo-sensitivity; doxorubicin; drug resistance; neuroblastoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transl Res Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google